[Recombinant activated Factor VII (Novo Seven) for uncontrollable hemorrhage in critically ill patients with multiple injuries].
Pernazza
F
F
Olearis
A
A
D001777:Blood Coagulation / Q000187:drug effects; D003422:Critical Care / Q000379:methods; D016638:Critical Illness; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D015942:Factor VIIa / Q000008:administration & dosage / Q000627:therapeutic use*; D006470:Hemorrhage / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D009104:Multiple Trauma / Q000150:complications* / Q000401:mortality; D011994:Recombinant Proteins / Q000627:therapeutic use; D016896:Treatment Outcome
D011994:Recombinant Proteins; D015942:Factor VIIa
Il fattore VII attivato ricombinante (Novo seven) come risposta all'emorragia incontrollabile in pazienti critici politraumatizzati.